Brothers Sudhir and Samir Mehta, who control $2.1 billion (revenues) Torrent Group, had a mixed year. The generics unit Torrent Pharma's shares were up 30%, but shares of its Torrent Power more than halved, plagued by gas supply problems and soaring interest costs. Their pharma unit has more than 500 scientists working on drug discovery and development